Skip to main content

Qiagen's FDA Letter Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Oct. 20.
 
1. FDA Claims Six of Qiagen's Artus Dxs Require Approval for Sale in US (from Oct. 17)
 
2. ABI President Cathy Burzik Steps Down; Applera CEO White Becomes Interim President (from Oct. 20)
 
3. Sanger and Solexa Use GAS to Sequence X Chromosome; Full Draft Genome Expected by Year End (from Oct. 18)
 
4. Baylor Researcher Wins $500K NHGRI Grant to Develop Improved SBS Instrument (from Oct. 16)
 
5. FTC Approves Thermo-Fisher Merger; Fisher to Divest Genevac Business (from Oct. 18)
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.